beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells

The Journal of Biological Chemistry
Jie WuRonald J Lukas

Abstract

Amyloid-beta (Abeta) accumulation and aggregation are thought to contribute to the pathogenesis of Alzheimer's disease (AD). In AD, there is a selective decrease in the numbers of radioligand binding sites corresponding to the most abundant nicotinic acetylcholine receptor (nAChR) subtype, which contains human alpha4 and beta2 subunits (halpha4beta2-nAChR). However, the relationships between these phenomena are uncertain, and effects of Abeta on halpha4beta2-nAChR function have not been investigated in detail. We first confirmed expression of halpha4 and hbeta2 subunits as messenger RNA in transfected, human SHEP1 cells by reverse transcription-polymerase chain reaction and mRNA fluorescence in situ hybridization analyses. Immunoprecipitation Western analyses confirmed alpha4 and beta2 subunit protein expression and co-assembly. Whole cell current recording demonstrated heterologous expression in SH-EP1-halpha4beta2 cells of functional halpha4beta2-nAChRs with characteristic responses to nicotinic agonists or antagonists. Nicotine-induced whole cell currents were suppressed by Abeta(1-42) in a dose-dependent manner. Functional inhibition was selective for Abeta(1-42) compared with the functionally inactive, control peptide Abet...Continue Reading

References

Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P Whiting, J Lindstrom
Mar 13, 1995·Brain Research·W E MüllerK Scheuer
Nov 23, 1994·Molecular and Cellular Biochemistry·N ArispeE Rojas
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·M HoshiK Imahori
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·J F KellyM P Mattson
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·W A PedersenJ K Blusztajn
Mar 1, 1997·Dementia and Geriatric Cognitive Disorders·A NordbergB Långström
Feb 17, 1998·Trends in Neurosciences·D S AuldR Quirion
Apr 8, 1998·Annual Review of Neuroscience·D L Price, S S Sisodia
Dec 11, 1999·Neurochemical Research·J N KanferD S Sitar
Feb 19, 2000·Biochemical and Biophysical Research Communications·Y M KuoA E Roher
Apr 12, 2000·Progress in Neurobiology·D Paterson, A Nordberg
Mar 7, 2001·Biological Psychiatry·J CourtE Perry
Mar 7, 2001·Biological Psychiatry·A H Rezvani, E D Levin
Mar 7, 2001·Biological Psychiatry·P A NewhouseJ Corwin
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·Q LiuD K Berg
May 2, 2002·The Journal of Biological Chemistry·Kelly T DineleyJ David Sweatt
Jun 11, 2002·Biochemical and Biophysical Research Communications·Hidetoshi TozakiTomoykui Nishizaki
Apr 3, 2003·Neuron·Flavio KamenetzRoberto Malinow

❮ Previous
Next ❯

Citations

Jan 12, 2013·Pflügers Archiv : European journal of physiology·Jerrel L Yakel
Aug 20, 2009·Journal of Molecular Neuroscience : MN·Sofia Jürgensen, Sergio T Ferreira
Sep 20, 2012·Chemical Reviews·Damien LemoineThomas Grutter
Sep 20, 2008·Nature Reviews. Neuroscience·Lars Bertram, Rudolph E Tanzi
Oct 11, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ping HeYong Shen
Mar 26, 2009·Learning & Memory·Ana Garcia-Osta, Cristina M Alberini
Sep 25, 2008·The Journal of Pharmacology and Experimental Therapeutics·Elaine A GayJerrel L Yakel
Mar 19, 2009·Pharmacological Reviews·Steven D BuckinghamDavid B Sattelle
Jan 8, 2009·Physiological Reviews·Edson X AlbuquerqueScott W Rogers
Jan 30, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Qiang LiuJie Wu
Aug 27, 2013·Brain : a Journal of Neurology·Hiroyuki OkadaYasuhiro Magata
Sep 1, 2007·Expert Opinion on Drug Discovery·Pm LippielloAa Mazurov
Oct 4, 2014·Frontiers in Synaptic Neuroscience·A Rory McQuiston
Jul 17, 2010·Neuropharmacology·Galya R AbdrakhmanovaF Ivy Carroll
Jan 15, 2005·Progress in Neurobiology·C Gotti, F Clementi
Jun 2, 2009·Journal of Neuroscience Methods·Serguei S SidachMerouane Bencherif
Oct 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gerald Koelsch
Aug 24, 2018·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Justin L HoskinMarwan Noel Sabbagh
Aug 5, 2009·Journal of Cellular and Molecular Medicine·Kim N Green
Jul 1, 2005·The Journal of Biological Chemistry·Margaret H MagdesianSérgio T Ferreira
Aug 7, 2010·The Journal of Pharmacology and Experimental Therapeutics·Chao ZhengJie Wu
Oct 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·Jun HuJie Wu
Oct 27, 2005·The Journal of Pharmacology and Experimental Therapeutics·Elaine A GayJerrel L Yakel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.